These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37265248)

  • 1. Chemobrain in blood cancers: How chemotherapeutics interfere with the brain's structure and functionality, immune system, and metabolic functions.
    Skurlova M; Holubova K; Kleteckova L; Kozak T; Kubova H; Horacek J; Vales K
    Med Res Rev; 2024 Jan; 44(1):5-22. PubMed ID: 37265248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Four decades of chemotherapy-induced cognitive dysfunction: comprehensive review of clinical, animal and in vitro studies, and insights of key initiating events.
    Dias-Carvalho A; Ferreira M; Ferreira R; Bastos ML; Sá SI; Capela JP; Carvalho F; Costa VM
    Arch Toxicol; 2022 Jan; 96(1):11-78. PubMed ID: 34725718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Imaging of Chemobrain: Usefulness of Nuclear Medicine in the Fog Coming After Cancer.
    Chiaravalloti A; Filippi L; Pagani M; Schillaci O
    J Nucl Med; 2023 Apr; 64(4):508-514. PubMed ID: 36732056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-chemotherapy cognitive impairment in hematological patients: current understanding of chemobrain in hematology.
    Allegra A; Innao V; Basile G; Pugliese M; Allegra AG; Pulvirenti N; Musolino C
    Expert Rev Hematol; 2020 Apr; 13(4):393-404. PubMed ID: 32129131
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemobrain: A review on mechanistic insight, targets and treatments.
    Rao V; Bhushan R; Kumari P; Cheruku SP; Ravichandiran V; Kumar N
    Adv Cancer Res; 2022; 155():29-76. PubMed ID: 35779876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemotherapy-induced cognitive impairment: focus on the intersection of oxidative stress and TNFα.
    Rummel NG; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
    Cell Mol Life Sci; 2021 Oct; 78(19-20):6533-6540. PubMed ID: 34424346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Berberine ameliorates doxorubicin-induced cognitive impairment (chemobrain) in rats.
    Shaker FH; El-Derany MO; Wahdan SA; El-Demerdash E; El-Mesallamy HO
    Life Sci; 2021 Mar; 269():119078. PubMed ID: 33460662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma entrainment using audiovisual stimuli alleviates chemobrain pathology and cognitive impairment induced by chemotherapy in mice.
    Kim T; James BT; Kahn MC; Blanco-Duque C; Abdurrob F; Islam MR; Lavoie NS; Kellis M; Tsai LH
    Sci Transl Med; 2024 Mar; 16(737):eadf4601. PubMed ID: 38446899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Review on the Neuroprotective Effect of Berberine against Chemotherapy- induced Cognitive Impairment.
    Sahu K; Singh S; Devi B; Singh C; Singh A
    Curr Drug Targets; 2022; 23(9):913-923. PubMed ID: 35240956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment.
    Ren X; St Clair DK; Butterfield DA
    Pharmacol Res; 2017 Mar; 117():267-273. PubMed ID: 28063894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review.
    Guran E; Hu J; Wefel JS; Chung C; Cata JP
    Br J Anaesth; 2022 Dec; 129(6):909-922. PubMed ID: 36270848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 Signaling Pathway: a Potential Therapeutic Target in Combating Oxidative Stress and Neurotoxicity in Chemotherapy-Induced Cognitive Impairment.
    Lal R; Dharavath RN; Chopra K
    Mol Neurobiol; 2024 Feb; 61(2):593-608. PubMed ID: 37644279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plausible biochemical mechanisms of chemotherapy-induced cognitive impairment ("chemobrain"), a condition that significantly impairs the quality of life of many cancer survivors.
    Ren X; Boriero D; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1088-1097. PubMed ID: 30759363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 2013 SFRBM discovery award: selected discoveries from the butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment.
    Butterfield DA
    Free Radic Biol Med; 2014 Sep; 74():157-74. PubMed ID: 24996204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In-vitro and in-vivo studies of two-drug cocktail therapy targeting chemobrain via the Nrf2/NF-κB signaling pathway.
    Singh A; Kumar V; Langeh U; Kapil L; Kaur S; Rana N; Bhattacharya A; Singh R; Bhatti JS; Singh C
    J Mol Histol; 2024 Aug; 55(4):599-625. PubMed ID: 39042217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The triangle of death of neurons: Oxidative damage, mitochondrial dysfunction, and loss of choline-containing biomolecules in brains of mice treated with doxorubicin. Advanced insights into mechanisms of chemotherapy induced cognitive impairment ("chemobrain") involving TNF-α.
    Ren X; Keeney JTR; Miriyala S; Noel T; Powell DK; Chaiswing L; Bondada S; St Clair DK; Butterfield DA
    Free Radic Biol Med; 2019 Apr; 134():1-8. PubMed ID: 30593843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemobrain - cognitive disorders after chemotherapy].
    Kupryjaniuk A; Sobstyl M
    Pol Merkur Lekarski; 2022 Dec; 50(300):398-400. PubMed ID: 36645690
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation.
    Ali MA; Menze ET; Tadros MG; Tolba MF
    Neuropharmacology; 2020 Dec; 181():108334. PubMed ID: 33011199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil Protects Against Doxorubicin-Induced Chemobrain in Rats via Attenuation of Inflammation and Oxidative Stress Without Interfering With Doxorubicin Efficacy.
    Ongnok B; Khuanjing T; Chunchai T; Pantiya P; Kerdphoo S; Arunsak B; Nawara W; Jaiwongkam T; Apaijai N; Chattipakorn N; Chattipakorn SC
    Neurotherapeutics; 2021 Jul; 18(3):2107-2125. PubMed ID: 34312765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in the elucidation of the mechanisms of chemotherapy-induced cognitive impairment.
    Alhowail AH; Aldubayan M
    Eur Rev Med Pharmacol Sci; 2021 Sep; 25(18):5807-5817. PubMed ID: 34604972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.